- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07833137
AI-Assisted Anaerobic Threshold Interpretation in Cardiopulmonary Exercise Testing (PACE-Reader)
A Randomized Two-Period Crossover Reader Study of Artificial Intelligence-Assisted Anaerobic Threshold Interpretation in Cardiopulmonary Exercise Testing
This prospective randomized two-period crossover reader study will evaluate whether assistance from a frozen artificial intelligence model improves physicians' interpretation of the anaerobic threshold (AT) in cardiopulmonary exercise testing (CPET). Sixteen physicians, including 8 senior and 8 junior readers, will each interpret 150 de-identified CPET examinations once without AI assistance and once with AI assistance. The primary outcome is the within-physician difference in absolute AT localization error between the assisted and unassisted conditions. Secondary outcomes include signed timing error, agreement on whether AT is present, estimates within 15 and 30 seconds of the reference, inter-reader reliability, interpretation time, and whether the effect of AI assistance differs by physician seniority.
Study Overview
Status
Conditions
Detailed Description
The 150 de-identified CPET examinations will be divided into two non-overlapping case libraries, X and Y, with 75 examinations in each library. The libraries will be balanced, as far as feasible, by clinical severity and acquisition characteristics. None of the reader-study examinations will be used for model training, hyperparameter selection, or checkpoint selection.
Within each seniority stratum, physicians will be randomized in a 1:1 ratio to Sequence A or Sequence B. In period 1, Sequence A will interpret library X without AI assistance and library Y with AI assistance; Sequence B will receive the opposite conditions. Following a 14 ± 3 day washout, the assistance conditions will be reversed in period 2. Case order will be randomized within each period, and new blinded task identifiers will be assigned in period 2. Thus, every physician will interpret every examination once without AI assistance and once with AI assistance, yielding 4,800 interpretations.
In the assisted condition, the interface will display the frozen model's predicted AT time. In the unassisted condition, no model output will be shown. Readers will be masked to case source, routine-report and reference-standard labels, other readers' annotations, and their own annotations from the previous period. For each examination, the reader will classify AT as confirmed, not reached, or unable to confirm. When AT is confirmed, the reader will record the AT time and the interpretive method used. Interpretation time will also be recorded.
The reference standard will be prespecified from unassisted senior-physician annotations. AT will be considered present when at least 6 of 8 senior physicians confirm it, and the reference AT time will be the median of the confirming senior estimates. AT will be considered not reached when at least 6 of 8 senior physicians make that classification. Discordant cases will undergo adjudication by an additional senior physician who is masked to model output and reader identity. For analyses of senior readers, a leave-one-reader-out reference will be used.
The primary analysis will compare absolute AT localization error between assisted and unassisted interpretations using a crossed mixed-effects model. Fixed effects will include assistance condition, physician seniority, the assistance-by-seniority interaction, period, randomized sequence, and case library. Random intercepts will be included for physician and examination. Estimates will be reported with 95% confidence intervals. No simulated or pilot-result data will be included in the prospective study analysis.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Cong Wang, MD, PhD
- Phone Number: +86-21-64041990
- Email: wang.cong1@zs-hospital.sh.cn
Study Locations
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200032
- Zhongshan Hospital, Fudan University
-
Contact:
- Cong Wang, MD, PhD
- Phone Number: +86-21-64041990
- Email: wang.cong1@zs-hospital.sh.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18 years or older.
- Licensed physician or physician enrolled in a recognized postgraduate clinical training program at the study institution.
- Eligible for one of the two prespecified seniority strata: senior physicians are attending physicians or above with at least 5 years of independent CPET interpretation experience; junior physicians are residents or specialty trainees with less than 5 years of independent CPET interpretation experience.
- Able to interpret CPET examinations and use the study interface after standardized orientation.
- Willing and able to complete both study periods and the prespecified washout interval.
- Provides written informed consent.
Exclusion Criteria:
- Direct involvement in development, training, hyperparameter selection, or checkpoint selection of the PACE-Former model.
- Prior access to the study case libraries, reference-standard annotations, or model outputs for the study examinations.
- Unable to complete the required interpretation tasks or the 14 ± 3 day washout interval.
- Withdrawal of consent before completion of study procedures.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sequence A
Period 1: library X interpreted without AI assistance and library Y interpreted with AI assistance. Period 2, after a 14 ± 3 day washout: library X interpreted with AI assistance and library Y interpreted without AI assistance. |
A frozen PACE-Former model provides a predicted anaerobic threshold time within the CPET review interface. Physicians retain responsibility for the final classification and AT time annotation. No other model output or reference label is displayed. The physician reviews the same de-identified CPET data using the study interface without display of any model prediction or AI-generated suggestion and independently classifies AT status and records the AT time when confirmed. |
|
Experimental: Sequence B
Period 1: library X interpreted with AI assistance and library Y interpreted without AI assistance. Period 2, after a 14 ± 3 day washout: library X interpreted without AI assistance and library Y interpreted with AI assistance. |
A frozen PACE-Former model provides a predicted anaerobic threshold time within the CPET review interface. Physicians retain responsibility for the final classification and AT time annotation. No other model output or reference label is displayed. The physician reviews the same de-identified CPET data using the study interface without display of any model prediction or AI-generated suggestion and independently classifies AT status and records the AT time when confirmed. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in Absolute Anaerobic Threshold Localization Error
Time Frame: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
Absolute difference, in seconds, between the physician-selected AT time and the prespecified expert reference AT time. The primary estimand is the within-physician difference between AI-assisted and unassisted interpretations, analyzed across the same examinations using a crossed mixed-effects model. |
Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Signed Anaerobic Threshold Localization Error
Time Frame: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
Signed difference, in seconds, between the physician-selected AT time and the prespecified expert reference AT time. Negative values indicate earlier placement and positive values indicate later placement relative to the reference. |
Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
|
Proportion of Anaerobic Threshold Estimates Within 15 Seconds of the Reference
Time Frame: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
Proportion of interpretable examinations for which the physician-selected AT time is within 15 seconds, in either direction, of the prespecified expert reference AT time. |
Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
|
Proportion of Anaerobic Threshold Estimates Within 30 Seconds of the Reference
Time Frame: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
Proportion of interpretable examinations for which the physician-selected AT time is within 30 seconds, in either direction, of the prespecified expert reference AT time. |
Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
|
Agreement With the Reference Anaerobic Threshold Status
Time Frame: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
Agreement between the physician classification (AT confirmed, AT not reached, or unable to confirm) and the prespecified expert reference classification. Results will be summarized as overall agreement and condition-specific classification performance. |
Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
|
Inter-Reader Reliability
Time Frame: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
Reliability among physicians for AT timing and AT-status classification under AI-assisted and unassisted conditions, summarized using appropriate intraclass correlation and chance-corrected agreement statistics with 95% confidence intervals. |
Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
|
Interpretation Time per Examination
Time Frame: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
Elapsed time, in seconds, from opening the blinded CPET task to submission of the physician's AT classification and, when applicable, the selected AT time. |
Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
|
Interaction Between AI Assistance and Physician Seniority
Time Frame: Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
Difference in the effect of AI assistance between senior and junior physicians, estimated from the prespecified assistance-by-seniority interaction term in the crossed mixed-effects model for absolute AT localization error. |
Recorded immediately after each case interpretation and analyzed after completion of both study periods, up to 2 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cong Wang, MD, PhD, Fudan University
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- PACE-AT-READER-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.